Fast Market Research

New Report Available: Neuron BioPharma - Product Pipeline Review - 2013

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

 
Repost This

Boston, MA -- (SBWIRE) -- 02/06/2014 -- Global Market Direct's pharmaceuticals report, "Neuron BioPharma - Product Pipeline Review - 2013" provides data on the Neuron BioPharma's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Neuron BioPharma's corporate website, SEC filings, investor presentations and featured press releases, both from Neuron BioPharma and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Neuron BioPharma - Brief Neuron BioPharma overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Neuron BioPharma human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Neuron BioPharma with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neuron BioPharma's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Neuron BioPharma's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neuron BioPharma in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neuron BioPharma's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neuron BioPharma.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neuron BioPharma and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Array BioPharma Inc. - Product Pipeline Review - 2013
- Hemispherx Biopharma, Inc. - Product Pipeline Review - 2013
- Canopus BioPharma Incorporated - Product Pipeline Review - 2013
- Soricimed Biopharma Inc. - Product Pipeline Review - 2013
- Lytix Biopharma AS - Product Pipeline Review - 2013
- Synageva BioPharma Corp. - Product Pipeline Review - 2013
- Alios BioPharma, Inc. - Product Pipeline Review - 2013
- Benitec Biopharma Limited - Product Pipeline Review - 2013
- Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013
- Valentia Biopharma S.L. - Product Pipeline Review - 2013